Skip to main content
. 2019 Aug;5(8):968–976. doi: 10.1016/j.jacep.2019.05.012

Table 1.

Study Characteristics

First Author (Ref. #) Acronym Year n Mean Age (yrs) Sex (% Males) Follow-Up (months) PVI Arm Analyzed Non-PVI Arm Primary Endpoint Endpoint Used for Analysis %PsAF Mean LA Diameter (mm) Mean LVEF (%) Hypertension (%) Absence of AADs Mandated Means of Detecting Recurrence
Chen et al. (11) NA 2011 118 56.1 66.5 22.6 ± 6.4 PVI CFAE Freedom from AF/AT Freedom from AF/AT 0 34.7 65.5 23 Yes ECG and 24-h Holter 3 days and 1, 3, 6 and 12 months post-procedure. Additional testing if symptomatic
Di Biase et al. (23) NA 2009 68 58.4 82.3 13.7 ± 2.2 PVI+CFAE CFAE Freedom from AF/AT Freedom from AF/AT 0 46.2 55 35.7 No Event recorder for 5 months with minimum 4 times per week recording. 48-h Holter at 3,6, 9, 12 and 15 months postprocedure
Katritsis et al. (24) NA 2013 164 56 66 24 PVI+GP GP Freedom from AF/AT Freedom from AF/AT 0 48.3 62.6 76.3 No Monthly Holter for 2 yrs, transtelephonic transmission when symptomatic. 50% of patients also received an ILR.
Mamchur et al. (25) NA 2014 79 56.6 60 16 PVI GP Freedom from AF Freedom from AF 100 46.2 45.9 Not reported No 24-h Holter, frequency not specified.
Atienza et al. (10) RADAR-AF 2014 113 53.5 78.6 12 PVI HFSA Freedom from AF Freedom from AF/AT 0 40 60 36.3 Yes ECG and 48-h Holter at 3, 6, and 12 months post-procedure.
Verma et al. (26) STAR AF 2010 68 57 74.3 12 PVI+CFAE CFAE Freedom from AF Freedom from AF/AT/AFL 35.7 41.6 61.7 44.9 No ECG and 48-h Holter at 3, 6, and 12 months post-procedure. External loop recorder and/or transtelephonic monitors used to confirm rhythm when symptomatic outside of follow-up visits.

AAD = antiarrhythmic drugs; AF = atrial fibrillation; AFL = atrial flutter; AT = atrial tachycardia; CFAE = complex fractionated atrial electrogram; ECG = electrocardiography; FIRM = focal impulse and rotor modulation; GP = ganglionated plexi; HFSA = high-frequency source ablation; ILR = implantable loop recorder; LA = left atrium; LVEF = left ventricular ejection fraction; NA = not applicable; PsAF = persistent AF; PVI = pulmonary vein isolation; RADAR-AF = Radiofrequency Ablation of Drivers of Atrial Fibrillation; STAR-AF = Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial.

Freedom from AF/AT was not reported.